Concepedia

Lynn A. Balanda

LA

Statistics

Publications

4

Citations

90

H-Index

4

Active since

2003

Affiliations

Bristol-Myers Squibb (United States)(Current)

Lynn A. Balanda is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, neuropharmacology, and receptor pharmacology.

Publications per year

2003–2007

4

Publications

4

A general liquid chromatography/mass spectroscopy-based assay for detection and quantitation of methyltransferase activity

Mary Ellen K. Salyan, Donna L. Pedicord, Laurie Bergeron et al. · Analytical Biochemistry · 2005 · 29 citations

, , +14

Signal Peptide Peptidase and γ-Secretase Share Equivalent Inhibitor Binding Pharmacology

Lawrence G. Iben, Richard E. Olson, Lynn A. Balanda et al. · Journal of Biological Chemistry · 2007 · 25 citations · Full text

, , +17

2-Arylaminothiazoles as high-affinity corticotropin-Releasing factor 1 receptor (CRF1R) antagonists: synthesis, binding studies and behavioral efficacy

Gene M. Dubowchik, Jodi A. Michne, Dmitry Zuev et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 20 citations · Full text

, , +5

Synthesis, structure–activity relationships, and anxiolytic activity of 7-aryl-6,7-dihydroimidazoimidazole corticotropin-releasing factor 1 receptor antagonists

Xiaojun Han, Jodi A. Michne, Sokhom S. Pin et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 16 citations · Full text

, , +13

1–4 of 4